Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 10/17/26
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulinReuters • 10/15/26
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience24/7 Wall Street • 10/15/26
Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)PRNewsWire • 10/14/26
JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech ChallengesZacks Investment Research • 10/14/26
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?Zacks Investment Research • 10/14/26
Johnson & Johnson Q3 Earnings: Talc Resolution Offer Impacts Earnings, MedTech Slows GrowthSeeking Alpha • 10/13/26
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow RunwayMarketBeat • 10/13/26
J&J Q3 Earnings Beat Estimates, Sales Miss, View Raised, Stock DownZacks Investment Research • 10/13/26
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff24/7 Wall Street • 10/13/26
Compared to Estimates, Johnson & Johnson (JNJ) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/13/26